Johnson & Johnson Investor Presentation — April 2024

Document content

April 16, 2024Cautionary note on Forward-looking statements

This presentation contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things: future operating and financial

performance, product development, and market position and business strategy. The viewer is cautioned not to rely on these forward-looking statements. These statements are based on current

expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and

projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: economic factors, such as interestrate and currency exchange rate fluctuations; competition, including

technological advances, new products and patents attained by competitors; challenges inherent in new product research and development, including uncertainty of clinical success and

obtaining regulatory approvals; uncertainty of commercial success for new and existing products; challenges to patents; the impact of patent expirations; the ability of the Company to

successfully execute strategic plans, including restructuring plans; the impact of business combinations and divestitures; manufacturing difficulties or delays, internally or within the supply

chain; product efficacy or safety concerns resulting in product recalls or regulatory action; significant adverse litigation or government action, including related to product liability claims;

changes to applicable laws and regulations, including tax laws and global health care reforms; trends toward health care costcontainment; changes in behavior and spending patterns of

purchasers of health care products and services; financial instability of international economies and legal systems and sovereign risk; increased scrutiny of the health care industry by